Pediatric formulation of gatifloxacin

摘要

A crystalline co-precipitate of gatifloxacin and a fatty acid in a ration of 1:1.8 to 1:2.3 is described wherein the fatty acid is selected from stearic acid, palmitic acid and mixtures thereof. The co-precipitate can be used in a pharmaceutical composition for oral administration to treat infections. Also described is process of forming the crystalline co-precipitate.